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Small intestineHormone sensitive lipase (HSL) regulates the hydrolysis of acylglycerols and cholesteryl esters (CE) in various
cells and organs, including enterocytes of the small intestine. The physiological role of this enzyme in
enterocytes, however, stayed elusive. In the present study we generated mice lacking HSL exclusively in
the small intestine (HSLiKO) to investigate the impact of HSL deﬁciency on intestinal lipid metabolism
and the consequences on whole body lipid homeostasis. Chow diet-fed HSLiKO mice showed unchanged
plasma lipid concentrations. In addition, feeding with high fat/high cholesterol (HF/HC) diet led to unaltered
triglyceride but increased plasma cholesterol concentrations and CE accumulation in the small intestine. The
same effect was observed after an acute cholesterol load. Gavaging of radioactively labeled cholesterol
resulted in increased abundance of radioactivity in plasma, liver and small intestine of HSLiKO mice 4 h
post-gavaging. However, cholesterol absorption determined by the fecal dual-isotope ratio method revealed
no signiﬁcant difference, suggesting that HSLiKOmice take up the same amount of cholesterol but in an accel-
eratedmanner. mRNA expression levels of genes involved in intestinal cholesterol transport and esteriﬁcation
were unchanged but we observed downregulation of HMG-CoA reductase and synthase and consequently
less intestinal cholesterol biosynthesis. Taken together our study demonstrates that the lack of intestinal
HSL leads to CE accumulation in the small intestine, accelerated cholesterol absorption and decreased choles-
terol biosynthesis, indicating that HSL plays an important role in intestinal cholesterol homeostasis.
© 2012 Elsevier B.V. Open access under CC BY-NC-ND license.1. Introduction
Plasma cholesterol concentrations represent a balance between
cholesterol absorption, cholesterol excretion and endogenous choles-
terol biosynthesis [1]. The pathways involved in cholesterol biosyn-
thesis have already been elucidated. The knowledge about regulatory
processes and the mechanisms responsible for cholesterol absorption,
however, is still incomplete.
Altmann et al. have recently identiﬁed Niemann–Pick C1 like 1
(NPC1L1) as target of ezetimibe, a potent cholesterol absorption inhib-
itor, thereby revealing NPC1L1 as the major cholesterol importer of
the small intestine [2]. Once taken up into the enterocytes, cholesterol
is esteriﬁed by acyl-CoA:cholesterol acyl transferase 2 (ACAT2), packed
together with triglycerides (TG), phospholipids and apolipoproteins
into chylomicrons and released into the lymph [3]. Dietary cholesterol
can also be efﬂuxed to high-density lipoprotein (HDL) via ATP-binding
cassette, subfamily A, member 1 (ABCA1). This process contributes to
approximately 30% of whole body plasma HDL cholesterol concentra-
tions [4]. In addition, cholesterol is expelled into the intestinal lumenratky).
-NC-ND license.by the ABCG5/ABCG8 heterodimeric transporter for excretion via the
feces [5]. The model of dietary cholesterol being esteriﬁed by ACAT2
and packed into chylomicrons is well established [3]. Whether the hy-
drolysis of cholesteryl esters (CE) plays a role in intestinal cholesterol
absorption and metabolism has not been investigated so far.
Dietary TG is taken up by enterocytes after being hydrolyzed in
the lumen of the small intestine. Once in the absorptive cells, fatty
acids are re-esteriﬁed and packed into chylomicrons or stored within
the enterocytes, thereby creating a TG storage pool [6]. This storage
pool was shown to be surrounded by lipid-droplet binding proteins,
to be ﬂexible in size and to become smaller during absorption [7].
Which enzyme(s) mobilize fatty acids from intestinal stored TG, how-
ever, is rather unknown.
Hormone sensitive lipase (HSL) is one of the major neutral CE
hydrolases in various tissues and cells like liver [8,9], adrenals [10],
small intestine [11], and macrophages [12]. Moreover, HSL is known
to efﬁciently hydrolyze a broad range of substrates like tri-, di, and
monoacylglycerols as well as retinyl esters [13]. Mice lacking HSL
have decreased nonesteriﬁed fatty acid (NEFA) and increased choles-
terol concentrations in plasma [14]. Decreased NEFA levels were
explained by less release of NEFAs from white adipose tissue (WAT)
resulting in reduced plasma TG concentrations [14]. The reason for the
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not completely understood. It has been recently reported that a modiﬁ-
cation of hepatic cholesterol metabolism, especially an impairment
of the scavenger receptor class B type 1 (SR-B1)-mediated uptake of
HDL-derived CE, might be responsible for elevated plasma HDL choles-
terol concentrations [8]. Previous ﬁndings suggested that HDL choles-
terol levels are increased in fasted HSL-deﬁcient mice due to enhanced
lipoprotein lipase activity in muscle and WAT [14]. Furthermore,
HSL-deﬁcient mice are resistant to diet-induced obesity [15].
Grober et al. reported that HSL is expressed throughout the small
intestine and that CE hydrolase activity is absent in HSL-deﬁcient
enterocytes. In addition, the authors observed a reduction of diglyceride
(DG) hydrolase activity in the jejunum and ileum of the small intestine
[11]. However, the role of HSL in the small intestine and the effect of its
deﬁciency on intestinal and whole body lipid metabolism remained
unclear. To address this question, we generated intestine-speciﬁc
HSL-deﬁcient (HSLiKO) mice. Our results demonstrate that HSL plays
a pivotal role as CE hydrolase in the small intestine by promoting
enterocyte CE hydrolysis. We provide evidence that deﬁciency of intes-
tinal HSL modulates intestinal cholesterol absorption and biosynthesis
and affects plasma cholesterol levels.
2. Theory
HSL-deﬁcient mice have reduced CE and acylglycerol hydrolase
activity in the small intestine, suggesting HSL to be involved in intes-
tinal cholesterol and TG metabolism. Since HSL deﬁciency has severe
consequences on lipid metabolism in several organs and cells, we hy-
pothesize that the lack of HSL in enterocytes modulates intestinal
lipid metabolism, thereby affecting overall lipid homeostasis.
3. Materials and methods
3.1. Animals and diets
The generation of HSLﬂox/ﬂox mice is described elsewhere [14].
Mice with intestine-speciﬁc deletion of HSL were generated by cross-
ing HSLﬂox/ﬂox mice with Villin-Cre transgenic mice [16] (provided by
Dr. S. Duncan, Medical College ofWisconsin, WI) to generate HSLﬂox/+
heterozygotes. These mice were then mated with HSLﬂox/ﬂox mice to
obtain HSLﬂox/ﬂox/Villin-Cre (HSLiKO) and HSLﬂox/ﬂox (control) mice.
All experiments were performed using female HSLiKO mice and
their corresponding control littermates aged between 12 and
16 weeks. Mice had free access to food and water under a 12-h light/
12-h dark cycle in a temperature-controlled environment. HSLiKO
and control mice were fed a normal chow diet (11.9% caloric intake
from fat; Ssniff®, Soest, Germany) or switched to a high fat/high cho-
lesterol (HF/HC) diet for 4 weeks at the age of 12 weeks. HF/HC diet
contained 30% (wt/wt) crude fat and 1% cholesterol (Ssniff®, Soest,
Germany). Mice fed a HF/HC diet were housed individually and the
food intake was monitored over a period of 3 days. Food intake was
calculated as g/day/mouse. All experiments were approved by the
Division of Genetic Engineering and Animal Experiments, Austrian
Federal Ministry of Science and Research (Vienna, Austria).
3.2. Plasma lipid analysis
Blood was collected from the retroorbital plexus and plasma was
prepared. TG, TC and NEFA concentrations were assayed in plasma
from overnight fasted mice using enzymatic kits according to manu-
facturer's protocol (DiaSys, Holzheim, Germany; Wako Chemicals
GmbH, Neuss, Germany). Two hundred μl plasma (pool from 5
mice) were subjected to fast protein liquid chromatography (FPLC)
(Pharmacia P-500) equipped with a Superose 6 column (Amersham
Biosciences, Piscataway, NJ) to separate lipoproteins. TC concentra-
tions in 500 μl lipoprotein fractions were measured enzymatically.3.3. Lipid analyses in small intestines and livers
Lipid parameters in the small intestine and in the liver of HSLiKO
and control mice fed chow or HF/HC diet for 4 weeks were analyzed
after a 4 h fasting period. The middle 1/3rd part of the small intestine
(jejunum) and livers from HSLiKO and control mice were collected
and the lipids were isolated by Folch extraction. The lipid extract was
dried under a stream of nitrogen. One hundred μl 1% Triton-X100 in
chloroform was added and dried again under nitrogen gas. Thereafter,
the sampleswere dissolved in 100 μl ddH2O, and TG, TC and free choles-
terol (FC) (DiaSys, Holzheim, Germany;Wako Chemicals GmbH, Neuss,
Germany) concentrations were measured enzymatically. CE concentra-
tions were calculated by subtracting FC from TC. All values were nor-
malized to protein concentrations. For measuring DG concentrations,
lipid extracts were separated by thin layer chromatography (TLC)
using n-hexane/diethylether/acetic acid (80/20/2, v/v/v). DG bands
were scraped, lipids were extracted and dissolved in 100 μl ddH2O
containing 1% Triton-X100. DG concentrations were measured using
an aclyglycerol kit (DiaSys, Holzheim, Germany).
3.4. Measurement of intestinal cholesterol uptake and absorption
Cholesterol uptake and absorption studies were performed as
previously described with minor modiﬁcations [17]. Brieﬂy, mice
fed chow diet were fasted for 4 h and gavaged with 100 μl corn oil
containing 2 μCi [3H]cholesterol (ARC Inc., St. Louis, MO) and 500 μg
cholesterol. Four h post-gavaging, mice were sacriﬁced and plasma,
livers and intestines were collected, digested in 1 ml 1N NaOH over-
night at 65 °C and radioactivity was determined by liquid scintillation
counting. Plasma samples from each genotype were pooled, 200 μl
were subjected to FPLC and the radioactivity in 500 μl fractions was
determined by liquid scintillation counting.
For measurement of the cholesterol absorption rate, mice fasted for
4 h were gavaged with 100 μl corn oil containing 2 μCi [3H]cholesterol
and 500 μg cholesterol. Four, 8, 12 and 24 h post-gavaging plasmawere
collected and radioactivity was determined by liquid scintillation
counting.
For determination of FC and CE concentrations, lipids from 250 mg
of 3 equal parts of the small intestine (duodenum, jejunum and ileum)
were extracted and separated by TLC using n-hexane/diethylether/
acetic acid (80/20/2, v/v/v). Radioactivity in FC- and CE-speciﬁc bands
was measured by liquid scintillation counting. For calculation of the
relative distribution the total amount of radioactivity in the small intes-
tine was set to 100% and the percentage of CE and FC was calculated.
3.5. Fractional cholesterol absorption
Fractional cholesterol absorption was measured by using the fecal
dual-isotope ratio method [17]. Brieﬂy, mice fed chow diet were fasted
for 4 h before they were given a single intragastric dose of 100 μl corn
oil containing 0.2 μCi [3H]sitostanol (ARC Inc., St. Louis, MO) and
0.1 μCi [14C]cholesterol (ARC Inc., St. Louis, MO). Feces were collected
for 48 h. Fecal lipids were isolated by Folch extraction and radioactivity
was determined by liquid scintillation counting. Fractional cholesterol
absorption was calculated by the following formula:
% absorption ¼ ððdose½14C : ½3H  fecal½14C : ½3HÞ=dose½14C : ½3HÞ∗100:
3.6. Measurement of intestinal TG absorption
We assessed dietary TG absorption using [3H]triolein (Perkin
Elmer, Boston, MA) as previously described [18] with minor modiﬁca-
tions. Brieﬂy, mice fed chow diet were fasted for 4 h. Thereafter, they
were intraperitoneally injected with the lipase inhibitor tyloxapol
(500 mg/kg in PBS) to prevent peripheral lipolysis. Thirty min after
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2 μCi [3H]triolein. Prior to tyloxapol injection and 2 as well as 4 h
post-gavaging, blood was taken and radioactivity and TG concentra-
tion were measured in the plasma. Four h post-gavaging, mice were
sacriﬁced, livers and intestines were collected, digested in 1 ml 1N
NaOH overnight at 65 °C and radioactivity was determined by liquid
scintillation counting. For determination of the distribution of lipid
classes, lipids were extracted from 250 mg jejunum and separated
by TLC using n-hexane/diethylether/acetic acid (80/20/2, v/v/v).
Bands resembling TG, DG, NEFA and phospholipids were cut and
radioactivity was measured by liquid scintillation counting.3.7. RNA isolation and quantitative real-time PCR
Total RNA from tissues was extracted using TriFast according to
the manufacturer's protocol (Peqlab, Erlangen, Germany). Two μg of
total RNA was reverse transcribed using the High Capacity cDNA Re-
verse Transcription Kit (Applied Biosystems, Carlsbad, CA). Quantita-
tive real-time PCR was performed on a Roche LightCycler 480 (Roche
Diagnostics, Palo Alto, CA) using the QuantiFastTM SYBR® Green PCR
Kit (Qiagen, Valencia, CA). Samples were analyzed in duplicate and
normalized to the expression of cyclophilin A as a reference gene.
Expression proﬁles and associated statistical parameters were deter-
mined using the public domain program Relative Expression Software
Tool — REST 2008 (http://www.gene-quantiﬁcation.com/download.
html) [19]. Primer sequences are available upon request.C
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Fig. 1.HSL is deleted speciﬁcally in the small intestine of HSLiKOmice. (A) HSL mRNA levels w
control tissues. mRNA levels were normalized to cyclophilin A as a reference gene. HSL mRN
**p≤0.01, ***p≤0.001. (B) Protein lysates of pools from 3 mice of each genotype were se
expression of β-actin was determined as loading control. (C) CE, (D) acylglycerol and (E
Data represent mean values (n=4)±SEM. **p≤0.01, ***p≤0.001.3.8. Western blotting analysis
Mucosal scrapings were sonicated (Labsonic B. Braun, Melsungen,
Germany) in RIPA buffer and protein concentrations were deter-
mined by Bradford assay. Tissue homogenates (pools of 3 mice)
were separated by 10% SDS-PAGE and transferred to a nitrocellulose
membrane. For detection of HSL protein, polyclonal anti-HSL anti-
body (Cell Signaling Technology, Danvers, MA) was used at a dilution
of 1:800. The protein expression of ß-actin was determined as loading
control using a monoclonal anti-mouse ß-actin antibody (1:5000)
(Santa Cruz Biotechnology, Heidelberg, Germany).3.9. CE, acylglycerol and retinyl ester hydrolase activity assay
Cytosolic fractions ofmucosal scrapingswere obtained by centrifu-
gation (14.000 rpm for 1 h at 4 °C). Forty μg of protein from cytosolic
fractions was used for each assay. Further steps were performed as
previously described [20]. Brieﬂy, 40 μg of protein emulsiﬁed in
100 μl of 100 mM potassium phosphate lysis buffer was incubated
with 100 μl CE-substrate (20 nmol cholesteryl oleate/assay, cholesteryl
[1-14C]oleate (50,000 cpm/nmol) (Amersham Biosciences, Piscataway,
NJ)), TG-substrate (25 nmol triolein/assay and 40,000 cpm/nmol
[9,10-3H]triolein (PerkinElmer,Waltham,MA)), or retinyl ester substrate
(10 nmol retinyl palmitate and 50,000 cpm/nmol retinyl [9,10(n)-3H]
palmitate), respectively. Each substrate contained 35.5 μg mixed mi-
celles of phosphatidylcholine and phosphatidylinositol (3:1, w:w).l
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Table 1
Plasma lipid parameters of mice fed chow diet or HF/HC diet for 4 weeks. TG, TC and
NEFA concentrations were determined enzymatically. Data are expressed as mean
values±SEM.
Chow (n=6–8) HF/HC (n=5–8)
TC
(mg/dl)
TG
(mg/dl)
NEFA
(mM)
TC
(mg/dl)
TG
(mg/dl)
NEFA
(mM)
Control 118±5.5 35.2±4.5 1.21±0.1 155±15.1 43.6±3.2 1.02±0.07
HSLiKO 119±5.8 30.2±3.3 1.09±0.1 202±17.9 42.9±4.3 0.98±0.1
1409S. Obrowsky et al. / Biochimica et Biophysica Acta 1821 (2012) 1406–1414After incubation at 37 °C for 1 h, the reactionwas terminated by adding
3.25 ml of methanol/chloroform/heptane (10:9:7) and 1 ml 100 mM
potassium carbonate (pH 10.5 with boric acid). After centrifugation
(800×g, 15 min, 4 °C), the radioactivity in 1 ml of the upper phase
was determined by liquid scintillation counting.
3.10. Intestinal cholesterol synthesis
Intestinal cholesterol biosynthesis was performed as described
previously [21] with minor modiﬁcations. Brieﬂy, mice fed chow
diet were orally gavaged with 200 μl PBS containing 4 μCi [3H]
mevalonic acid (Perkin Elmer, Boston, MA). One h later the proximal
part of the intestine (duodenum and jejunum) was collected and the
lipids were extracted. FC and CE fractions were separated by TLC
using n-hexane/diethylether/acetic acid (80/20/2, v/v/v). FC- and
CE-speciﬁc bands were cut out and radioactivity was determined by
liquid scintillation counting. TC data represent the sum of counts
detected in CE- and FC-speciﬁc bands.
3.11. Gut transit
Overnight fasted mice were gavaged with 200 μl Evans blue sus-
pension (5% Evans blue, 5% gum Arabic in PBS). Afterwards mice
had free access to food and water and the duration until the detection
of Evans blue in the feces was recorded.
3.12. Statistical analysis
Statistical differences between groups were analyzed using un-
paired Student's t-test (GraphPad Prism 5.0, San Diego, CA). Data are
reported as means±SEM for the speciﬁed number of animals.
*p≤0.05, **p≤0.01 and ***p≤0.001 indicate signiﬁcant difference be-
tween HSLiKO and control mice.A BChow
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4.1. CE hydrolase activity is almost abolished in small intestines of HSLiKO
mice
First we compared HSL mRNA expression and activity in several
tissues of control mice. Although less than in WAT, HSL mRNA was
expressed in all three parts of the small intestine (duodenum, jejunum
and ileum) (Supplemental Fig. S1A), in whichwe observed substantial
CE hydrolase activities (Supplemental Fig. S1B).
To elucidate the physiological function of intestinal HSL on whole
body lipid homeostasis and to exclude systemic effects of a whole
body knockout on intestinal lipid metabolism, we eliminated HSL
from the intestinal epithelium. To conﬁrm HSL deletion in adult
HSLiKO intestine, we isolated duodenum, jejunum, and ileum and
examined HSL mRNA and protein expression by real time PCR and
Western blotting experiments, respectively. HSL mRNAwas markedly
downregulated throughout the small intestine of HSLiKO mice
compared to control mice, whereas no differences were observed in
WAT, liver, kidney, skeletal muscle and heart (Fig. 1A). HSL protein
expression was undetectable in HSLiKO duodenum, jejunum and
ileum (Fig. 1B). Consequently, we found strongly decreased CE hy-
drolase activity in all three parts of the small intestine (Fig. 1C).
Acylglycerol hydrolase was signiﬁcantly less (45%) in jejunum of
HSLiKO compared to control mice, but unchanged in duodenum
and ileum (Fig. 1D). Retinyl ester hydrolase activity was decreased
in jejunum (56%) and ileum (29%) but unaltered in duodenum
(Fig. 1E). These results suggest that HSL is a major neutral CE hydro-
lase in the small intestine and plays possible roles as acylglycerol or
retinyl ester hydrolase.4.2. Increased plasma cholesterol levels in HSLiKO mice fed a HF/HC diet
We fed control and HSLiKO mice chow diet or challenged the mice
with HF/HC diet for 4 weeks. Food intake and body weight were com-
parable between HSLiKO and control mice (Supplemental Fig. S2A, B).
No signiﬁcant differences were found in lipid parameters of chow
diet-fed mice and in TG and NEFA concentrations of HF/HC diet-fed
mice (Table 1). In contrast, we observed a tendency toward increased
plasma TC concentrations (1.3-fold, p=0.07) in HSLiKO mice fed a
HF/HC diet (Table 1).
Lipoprotein proﬁles revealed unaltered cholesterol distribution in
chow diet-fed HSLiKO mice (Fig. 2A) but increased cholesterol levels
in the HDL fraction (1.3-fold) when fed a HF/HC diet (Fig. 2B).0 10 20 30 40
fraction
HF/HC
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µg
 T
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ct
io
n
VLDL
HDL
LDL
C after fast performance liquid chromatography separation of pooled plasma frommice
ined spectrophotometrically.
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To investigate the impact of decreased CE hydrolase activity on
intestinal cholesterol concentrations, we measured intestinal TC, FC
and CE concentrations in mice fed either chow or HF/HC diets. HSLiKO
and control mice fed chow diet had comparable cholesterol levels
in the small intestine (Fig. 3A). When challenged with HF/HC diet,
HSLiKO mice showed markedly elevated CE levels by 2.1-fold com-
pared to control mice (Fig. 3B). To clarify if the accumulated CE in
HSLiKO mice originates from dietary sources we gavaged mice
with [3H]cholesterol. We observed a drastic increase by 2.8-fold of
radioactivity in the CE fraction of HSLiKO compared to control small
intestines with signiﬁcant increases in the duodenum and jejunum
(1.9- and 3.4-fold, respectively) (Fig. 3C). The amount of radioactivity
in FC fractions was unaltered (Fig. 3D). Calculation of the relativeA B
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FC to CE in HSLiKO compared to control small intestines (Fig. 3E).
Since HSL is known to hydrolyze acylglycerols and we observed
reduced acylglycerol hydrolase activity, we also measured TG and
DG concentrations in the jejunum. No signiﬁcant differences were
observed between HSLiKO and control mice (Fig. 3F, G). To ﬁgure
out if the lack of intestinal HSL modulates hepatic lipid content,
we determined cholesterol and TG concentrations in the liver. We
found unaltered hepatic lipid levels in HSLiKO compared to control
mice (Fig. 4A, B).
4.4. Intestinal HSL deﬁciency modulates intestinal cholesterol uptake
Grober et al. suggested a role of HSL in cholesterol absorption by
inﬂuencing the efﬂux of FC by ABC transporters [11]. We thereforeC
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intestine 4 h after an acute [3H]cholesterol load. We found 1.4-fold
more radioactivity in plasma of HSLiKO compared to control mice
(Fig. 5A). Lipoprotein proﬁling revealed that the increased amount
of radioactivity in the plasma was found throughout all lipoprotein
fractions (Fig. 5B). We also observed elevated amounts of radioactiv-
ity in livers (Fig. 5C) and small intestines of HSLiKO mice (Fig. 5D). In
addition, we determined fractional cholesterol absorption by using
the fecal dual-isotope ratio method but detected no differences
in the two genotypes (Fig. 5E). Moreover, we measured cholesterol
absorption rate over a period of 24 h and found differences in the
plasma only 4 h post-gavaging (Fig. 5F). These results indicate that
the same amount of cholesterol is taken up in HSLiKO mice but
the uptake into the body is accelerated compared to control mice.
We therefore investigated whether gut motility might be altered in
HSLiKO mice. As shown in Fig. 5G, however, gut transit is identical
in both genotypes. Small intestinal mRNA expression in 4 h fasted
mice revealed that genes involved in cholesterol uptake and absorp-
tion (ABCA1, ABCG5, ABCG8, NPC1L1 and ACAT2) showed compara-
ble mRNA abundances in both genotypes (Fig. 5H). These data
suggest that the increased accumulation of radioactivity in liver and
plasma of HSLiKOmice after an acute oral cholesterol load is indepen-
dent on the intestinal expression of these genes.
4.5. Intestinal cholesterol biosynthesis is decreased in HSLiKO mice
Previous studies reported that HSL deﬁciency is associated with a
decrease in hepatic mRNA expression of genes involved in cholesterol
biosynthesis [8,9]. We therefore measured mRNA expression of intes-
tinal 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase (HMG-CoR)
and HMG-CoA synthase (HMG-CoS), two key enzymes of cholesterol
biosynthesis. HMG-CoR mRNA was downregulated in jejunum but
unchanged in duodenum and ileum of HSLiKO mice (Fig. 6A).
HMG-CoS mRNA was downregulated in duodenum and jejunum of
HSLiKO compared to control mice. TC and CE biosynthesis in the
proximal intestine measured from orally administered [3H]mevalonic
acid was decreased by 18% and 21%, respectively, in HSLiKO com-
pared to control small intestines (Fig. 6B).
4.6. TG absorption is unchanged in HSLiKO mice
To investigate if the lack of intestinal HSL has a consequence on
intestinal TG absorption we injected tyloxapol to inhibit peripheral
lipolysis in HSLiKO and control mice and then gavaged [3H]trioleate
provided in corn oil. Plasma TG levels were unchanged between
HSLiKO and control mice during absorption (Fig. 7A). Furthermore,
counts in plasma, liver and small intestine were unaltered (Fig. 7B,C andD), suggesting no difference in TG absorption. To clarifywhether
HSL deﬁciencymodulates lipid composition, we analyzed the distribu-
tion of radioactivity in various lipid classes in the jejunum after
gavaging [3H]trioleate. HSL deﬁciency had no effect on the incorpora-
tion of radioactivity into any lipid species indicating that HSL lacks an
important role in intestinal acylglycerol metabolism (Fig. 7E).
5. Discussion
For decades HSL was thought to be the major TG hydrolase
in many cells and organs [22]. Recent data have shown that adipose
triglyceride lipase (ATGL) is the main cytosolic TG hydrolase in WAT
and also plays an important role in other tissues and cells like skeletal
muscle, heart, liver, and macrophages [20,23–27]. We detected de-
creased acylglycerol hydrolase activity in the jejunum of HSLiKO
mice, which is in agreement with previous data reporting that DG hy-
drolase activity was signiﬁcantly reduced in jejunum of HSL-deﬁcient
mice [11]. The decreased acylglycerol hydrolase activity, however,
failed to result in accumulation of intestinal TG or DG, respectively.
Zhu et al. have recently reported that lipid droplets are formed in
enterocytes during TG absorption, indicating that an intracellular
lipase might play a role in this process [7]. Our ﬁndings argue against
an important role of HSL in TG absorption and suggest that other
lipases are involved in the hydrolysis of acylglycerols in enterocytes.
One candidate is intestinal pancreatic triglyceride lipase (iPTL),
which was shown to be an acylglycerol hydrolase in enterocytes of
the small intestine [28]. Although this enzyme is regulated by dietary
fat it is currently unknown, whether iPTL is involved in TG absorption.
Another possible candidate is ATGL. ATGL-deﬁcient mice accumulate
TG in the ileum [23], suggesting a role of ATGL also in intestinal
TG metabolism. In addition, one further candidate is lysosomal acid
lipase (LAL). LAL-deﬁcient mice accumulate TG and TC in the small
intestine [29]. Moreover, the knockdown of magro, a homolog of LAL
in ﬂies, results in CE accumulation in the gut [30]. Compared to HSL,
ATGL and iPTL, however, LAL is not a cytosolic enzyme and exerts its
maximum activity at low pH conditions.
HSL was shown to be a CE hydrolase in various tissues and cells
like liver, macrophages, adrenal glands, pancreas, and in the small
intestine [8–12,31]. The accumulation of CE, however, was observed
only under special circumstances. Two recent publications showed
that CE accumulated in livers of HSL-deﬁcient mice solely if they
were fed HF or HC diets [8,9].
Compared to liver HSL mRNA is more abundant in the small intes-
tine. Although less than WAT, the small intestine exhibits increased
CE hydrolase activity levels compared to liver, kidney, cardiac and
skeletal muscle. In the present study we show that the disruption
of intestinal HSL results in a modulation of intestinal cholesterol
metabolism. In the small intestine we observed CE accumulation
under two different conditions: ﬁrstly, after 4 weeks of HF/HC diet
feeding and secondly, after an intragastric gavage with high amounts
of cholesterol. These results suggest that HSL not only has in vitro CE
hydrolase activity in the small intestine but also plays a crucial role
in CE hydrolysis in enterocytes in vivo. Since CE accumulation was
observed after HF/HC feeding and after intragastric cholesterol load,
it is very likely that HSL hydrolyzes CE, from which FC is absorbed
by the enterocytes.
HSL modulates the transcription of genes involved in cholesterol
biosynthesis [8,9,32]. Data obtained from livers of HSL-deﬁcient
mice revealed that in the absence of HSL several cholesterogenic
genes are downregulated [8,9]. Accordingly, cells overexpressing
HSL showed increased HMG-CoR activity and increased cholesterol
biosynthesis [32]. In agreement with these data, we found that the
lack of HSL in the small intestine resulted in a downregulation of
HMG-CoR and HMG-CoS mRNA and consequently in a decrease of in-
testinal cholesterol biosynthesis. Although the relationship between
cholesterol biosynthesis and HSL is still unknown, we speculate that
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Fig. 5. Accelerated cholesterol absorption into plasma, liver and small intestine of HSLiKOmice. Mice fed chow diet were gavagedwith 100 μl corn oil containing 2 μCi [3H]cholesterol
and 500 μg cholesterol. Four h after gavaging, (A) plasma, (C) liver and (D) small intestine were collected and radioactivity was determined by liquid scintillation counting. Data
represent mean values (n=6)±SEM. *p≤0.05. (B) Plasma samples from each genotype were pooled and 200 μl was subjected to fast protein liquid chromatography using a
Superose 6 column. [3H]Cholesterol in each fraction was determined by liquid scintillation counting. (E) Fractional cholesterol absorption was measured by the fecal dual-isotope
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cholesterol. Radioactivity in plasma was measured 4, 8, 12 and 24 h post-gavaging. (G) Mice were gavaged with 200 μl Evans blue and gut transit was determined by measuring
the time until the ﬁrst blue drop appeared in the feces. Data represent mean values (n=3–4)±SEM. (H) mRNA expression of genes involved in intestinal cholesterol uptake
and absorption were analyzed by real time PCR and normalized to the expression of cyclophilin A as a reference gene. mRNA levels in control mice were arbitrarily set to 1. Values
represent means (n=3)±SEM.
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unchanged CE concentrations as observed in mice fed chow diet.
Cholesterol-enriched diet caused a strong reduction of HMG-CoR activ-
ity [33] and almost undetectable levels of HMG-CoR and HMG-CoS
mRNA in small intestines of control mice ([21] and Supplemental Fig.
S3). HSLiKOmice fed aHF/HCdietmight no longer be able to counteract
the increasing availability of CE by reducing cholesterol biosynthesis,
which consequently leads to CE accumulation in the small intestine
of HF/HC diet-fed HSLiKO mice.
Despite the fact that the small intestine is a highly cholesterogenic
organ, which under certain physiological circumstances has a higher
cholesterol biosynthesis rate than the liver, the gut is mainly known
to absorb cholesterol and regulate its uptake [33]. HSL could play
a role in cholesterol absorption for several reasons: (i) HSL might
provide FC to be efﬂuxed back into the intestinal lumen. In this case,
HSL deﬁciency results in increased or at least accelerated cholesterol
absorption. (ii) HSL might supply FC to lipidate HDL. In that case,
reduced HDL cholesterol is the consequence of intestinal lack of
HSL. (iii) The lack of HSL could modulate the expression of genes
involved in intestinal cholesterol metabolism, thereby inﬂuencing
cholesterol absorption. In the present study, we observed an earlier
appearance of [3H]cholesterol in plasma and liver of HSLiKO mice
4 h post-gavaging but fractional cholesterol absorptionwas unaltered.
These results implicate that the same amount of cholesterol is taken
up in HSLiKO mice but in an accelerated manner, possibly due to less
efﬂux back into the intestinal lumen by ABCG5/G8. We speculate
that in the case of intestinal HSL deﬁciency less FC is pumped back
out into the intestinal lumen and consequently more cholesterol can
be found in the circulation 4 h post-gavaging. Since HSL deﬁciency
did not modulate mRNA levels of genes involved in cholesterol
absorption, we conclude that accelerated absorption in HSLiKO mice
is independent on expressions of these genes. Since we found more
radioactive tracer in the HDL fraction after gavaging [3H]cholesterol,
we conclude that HSL is not responsible for providing ABCA1 with
FC, at least not in the small intestine. A faster gut transit could be anexplanation for the observed accelerated cholesterol absorption in
HSLiKO mice. Determination of gut transit time, however, revealed
no difference between control and HSLiKO mice. It is important to
mention that gut transit was evaluated under different conditions
compared with the cholesterol uptake study. Thus the transit of corn
oil in the small intestine is not directly reﬂected by this experiment.
Since ACAT2 catalyzes the opposite reaction to that of HSL one
would expect opposing effects in ACAT2-deﬁcient compared to
HSLiKO mice. This is indeed the case because (compared to control
mice) ACAT2-deﬁcient mice have decreased intestinal CE concentra-
tions when fed a cholesterol-enriched diet [34]. In addition, thoracic
lymph duct cannulation revealed a delayed appearance of radioactive
cholesterol in lymph [3]. The lack of ACAT2, however, results in a
decrease in fractional cholesterol absorption. This is very likely due to
a modulation of liver X receptor (LXR) target genes, like upregulation
of ABCG5 and downregulation of NPC1L1 by elevated FC levels [3,35].
Thus a downregulation of LXR targets in HSL-deﬁcient conditions (due
to less availability of FC) might be expected. Nevertheless, we observed
unaltered FC concentrations and consequently no downregulation of
LXR target genes in the intestines of HSLiKO mice.
Although intestinal HSL deﬁciency markedly affected cholesterol
homeostasis in the small intestine, the consequences on whole body
lipid metabolism were only marginal. Hepatic and plasma lipid
parameters were comparable between HSLiKO and control mice fed
chow diet. When fed a HF/HC diet, plasma cholesterol concentrations
showed a tendency to elevated levels with enhancement of HDL
cholesterol. These data demonstrate that beside changes in liver
gene expressions and lipoprotein lipase activity the small intestine
also contributes to increased cholesterol levels in HSL-deﬁcient mice,
at least when mice are challenged with high amounts of fat and cho-
lesterol. Increased lipoprotein lipase expression in muscle and WAT
[14] as well as reduced HDL-CE uptake by hepatic SR-B1 (despite
unchanged SR-B1 expression) [8] are possible reasons for elevated
HDL-cholesterol levels in whole body HSL-deﬁcient mice. Enterocytes
also take up HDL cholesterol [36]. As discussed in the livers of
1414 S. Obrowsky et al. / Biochimica et Biophysica Acta 1821 (2012) 1406–1414HSL-deﬁcient mice [8], less HDL-CE clearance despite unaltered SR-B1
expression (data not shown) is conceivable in small intestines of HF/HC
diet-fed HSLiKO mice.
In conclusion, our study demonstrates that disruption of intestinal
HSL modulates intestinal cholesterol but not TG metabolism. Accu-
mulation of CE in the intestine, accelerated cholesterol absorption
and reduced intestinal cholesterol biosynthesis highlight the role
of HSL as an important player in intestinal cholesterol metabolism
in vivo.
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